FIELD: medicine.
SUBSTANCE: invention relates to field of medicine, namely to "methods of medication delivery into patient's organism". In treatment of metabolic irregularities, medication is introduced to patient through lateral ventricle of cerebrum at such a rate that introduction of one dose takes more than 2 hours. Rate of introduction can also be selected on the basis of total time of cerebrospinal fluid circulation. The rate is set in such a way that it takes at least 50% of its circulation or until medication starts to be detected in patient's blood serum.
EFFECT: method extends arsenal of means for medication delivery into patient's organism.
53 cl, 4 tbl, 8 dwg, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| INTRAVENTRICULAR DELIVERY OF ENZYMES IN CASE OF LYSOSOMAL STORAGE DISEASES | 2007 |
|
RU2529830C2 |
| INTRAVENTRICULAR DELIVERY OF ENZYMES IN LYSOSOMAL STORAGE DISEASES | 2014 |
|
RU2665381C2 |
| ENZYME REPLACEMENT THERAPY WITH DOSE INCREASE FOR TREATMENT OF ACID SPHINGOMYELINASE DEFICIENCY | 2010 |
|
RU2569744C2 |
| ENZYMATIC REPLACEMENT THERAPY WITH DOSE INCREASE FOR TREATING ACID SPHINGOMYELINASE DEFICIENCY | 2010 |
|
RU2731616C2 |
| METHODS AND COMPOSITIONS FOR BRAIN DISEASES TREATMENT | 2014 |
|
RU2664471C2 |
| ADENO-ASSOCIATED VIRUS MEDIATED GENE TRANSFER TO CENTRAL NERVOUS SYSTEM | 2014 |
|
RU2692251C2 |
| ADENO-ASSOCIATED VIRUS-MEDIATED GENE TRANSFER INTO THE CENTRAL NERVOUS SYSTEM | 2014 |
|
RU2801511C1 |
| DRUG FOR THE TREATMENT OF METACHROMATIC LEUKODYSTROPHY AND A METHOD FOR ITS TREATMENT | 2021 |
|
RU2769577C1 |
| USE OF HSP70 AS ENZYME ACTIVITY REGULATOR | 2009 |
|
RU2571946C2 |
| METHODS AND COMPOSITIONS FOR TREATING AMYLOID DEPOSITS | 2013 |
|
RU2673484C2 |
